NZ545248A - Wound dressings - Google Patents
Wound dressingsInfo
- Publication number
- NZ545248A NZ545248A NZ545248A NZ54524802A NZ545248A NZ 545248 A NZ545248 A NZ 545248A NZ 545248 A NZ545248 A NZ 545248A NZ 54524802 A NZ54524802 A NZ 54524802A NZ 545248 A NZ545248 A NZ 545248A
- Authority
- NZ
- New Zealand
- Prior art keywords
- layer
- honey
- wound
- mixture
- fabric
- Prior art date
Links
- 235000012907 honey Nutrition 0.000 claims abstract description 100
- 239000004744 fabric Substances 0.000 claims abstract description 71
- 239000000203 mixture Substances 0.000 claims abstract description 64
- 239000006096 absorbing agent Substances 0.000 claims abstract description 35
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 22
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 claims abstract description 18
- 235000010413 sodium alginate Nutrition 0.000 claims abstract description 18
- 239000000661 sodium alginate Substances 0.000 claims abstract description 18
- 229940005550 sodium alginate Drugs 0.000 claims abstract description 18
- 239000000843 powder Substances 0.000 claims abstract description 10
- 229920002134 Carboxymethyl cellulose Polymers 0.000 claims abstract description 7
- 239000001768 carboxy methyl cellulose Substances 0.000 claims abstract description 6
- 239000010410 layer Substances 0.000 claims description 95
- 239000007788 liquid Substances 0.000 claims description 31
- 239000000463 material Substances 0.000 claims description 16
- 238000000034 method Methods 0.000 claims description 13
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical group O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 claims description 12
- 239000012790 adhesive layer Substances 0.000 claims description 12
- 235000010410 calcium alginate Nutrition 0.000 claims description 12
- 239000000648 calcium alginate Substances 0.000 claims description 12
- 229960002681 calcium alginate Drugs 0.000 claims description 12
- OKHHGHGGPDJQHR-YMOPUZKJSA-L calcium;(2s,3s,4s,5s,6r)-6-[(2r,3s,4r,5s,6r)-2-carboxy-6-[(2r,3s,4r,5s,6r)-2-carboxylato-4,5,6-trihydroxyoxan-3-yl]oxy-4,5-dihydroxyoxan-3-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylate Chemical group [Ca+2].O[C@@H]1[C@H](O)[C@H](O)O[C@@H](C([O-])=O)[C@H]1O[C@H]1[C@@H](O)[C@@H](O)[C@H](O[C@H]2[C@H]([C@@H](O)[C@H](O)[C@H](O2)C([O-])=O)O)[C@H](C(O)=O)O1 OKHHGHGGPDJQHR-YMOPUZKJSA-L 0.000 claims description 12
- 229940072056 alginate Drugs 0.000 claims description 11
- 235000010443 alginic acid Nutrition 0.000 claims description 11
- 229920000615 alginic acid Polymers 0.000 claims description 11
- 239000000853 adhesive Substances 0.000 claims description 7
- 239000012530 fluid Substances 0.000 claims description 7
- 230000001070 adhesive effect Effects 0.000 claims description 6
- 230000005540 biological transmission Effects 0.000 claims description 6
- 235000010948 carboxy methyl cellulose Nutrition 0.000 claims description 5
- 239000008112 carboxymethyl-cellulose Substances 0.000 claims description 5
- 239000003795 chemical substances by application Substances 0.000 claims description 4
- 238000005470 impregnation Methods 0.000 claims description 4
- 238000004519 manufacturing process Methods 0.000 claims description 4
- 238000001125 extrusion Methods 0.000 claims description 3
- 238000003892 spreading Methods 0.000 claims description 3
- 230000007480 spreading Effects 0.000 claims description 3
- 239000007787 solid Substances 0.000 claims 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 abstract 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 abstract 1
- 206010052428 Wound Diseases 0.000 description 41
- 208000027418 Wounds and injury Diseases 0.000 description 41
- 239000002131 composite material Substances 0.000 description 8
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 7
- 239000004745 nonwoven fabric Substances 0.000 description 7
- 239000011780 sodium chloride Substances 0.000 description 6
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 5
- 230000000845 anti-microbial effect Effects 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 238000010438 heat treatment Methods 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 238000010521 absorption reaction Methods 0.000 description 4
- 235000016887 Leptospermum scoparium Nutrition 0.000 description 3
- 240000003553 Leptospermum scoparium Species 0.000 description 3
- 239000012071 phase Substances 0.000 description 3
- 229920000728 polyester Polymers 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 239000013589 supplement Substances 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 108010015776 Glucose oxidase Proteins 0.000 description 2
- 239000004366 Glucose oxidase Substances 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 2
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- 230000003444 anaesthetic effect Effects 0.000 description 2
- 239000004599 antimicrobial Substances 0.000 description 2
- 238000003490 calendering Methods 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 239000000306 component Substances 0.000 description 2
- 238000010894 electron beam technology Methods 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 229940116332 glucose oxidase Drugs 0.000 description 2
- 235000019420 glucose oxidase Nutrition 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 229910052709 silver Inorganic materials 0.000 description 2
- 239000004332 silver Substances 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 239000003357 wound healing promoting agent Substances 0.000 description 2
- CPKVUHPKYQGHMW-UHFFFAOYSA-N 1-ethenylpyrrolidin-2-one;molecular iodine Chemical compound II.C=CN1CCCC1=O CPKVUHPKYQGHMW-UHFFFAOYSA-N 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 241000257303 Hymenoptera Species 0.000 description 1
- 229920000153 Povidone-iodine Polymers 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 239000003463 adsorbent Substances 0.000 description 1
- 229940124326 anaesthetic agent Drugs 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 239000012298 atmosphere Substances 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000001804 debridement Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 230000003292 diminished effect Effects 0.000 description 1
- 238000001493 electron microscopy Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 238000009998 heat setting Methods 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 229960004393 lidocaine hydrochloride Drugs 0.000 description 1
- YECIFGHRMFEPJK-UHFFFAOYSA-N lidocaine hydrochloride monohydrate Chemical compound O.[Cl-].CC[NH+](CC)CC(=O)NC1=C(C)C=CC=C1C YECIFGHRMFEPJK-UHFFFAOYSA-N 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- 230000001338 necrotic effect Effects 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- -1 or an anaesthetic Substances 0.000 description 1
- 229910052763 palladium Inorganic materials 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 239000005426 pharmaceutical component Substances 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 229960001621 povidone-iodine Drugs 0.000 description 1
- 230000036573 scar formation Effects 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 239000003009 skin protective agent Substances 0.000 description 1
- 239000007790 solid phase Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 239000002759 woven fabric Substances 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/44—Medicaments
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
- A61L15/225—Mixtures of macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/30—Compounds of undetermined constitution extracted from natural sources, e.g. Aloe Vera
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
- A61L2300/606—Coatings
- A61L2300/608—Coatings having two or more layers
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Hematology (AREA)
- Materials For Medical Uses (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Laminated Bodies (AREA)
- Making Paper Articles (AREA)
- Winding Filamentary Materials (AREA)
- Manufacture Of Motors, Generators (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0128936A GB2382527A (en) | 2001-12-03 | 2001-12-03 | Wound dressings |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ545248A true NZ545248A (en) | 2008-02-29 |
Family
ID=9926921
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ545248A NZ545248A (en) | 2001-12-03 | 2002-12-02 | Wound dressings |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US20050033213A1 (enExample) |
| EP (1) | EP1450871B1 (enExample) |
| JP (1) | JP2005511146A (enExample) |
| AT (1) | ATE439149T1 (enExample) |
| AU (1) | AU2002365662B2 (enExample) |
| CA (1) | CA2469033C (enExample) |
| DE (1) | DE60233343D1 (enExample) |
| ES (1) | ES2333112T3 (enExample) |
| GB (1) | GB2382527A (enExample) |
| NZ (1) | NZ545248A (enExample) |
| WO (1) | WO2003047642A1 (enExample) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12419917B2 (en) | 2021-04-23 | 2025-09-23 | Ndal Mfg Inc | Compositions and methods for treatment of conditions using fractionated honey |
Families Citing this family (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU781878B2 (en) * | 1999-12-09 | 2005-06-16 | Derma Sciences, Inc. | Use of honey in medical dressings |
| GB2382527A (en) | 2001-12-03 | 2003-06-04 | Acordis Speciality Fibres Ltd | Wound dressings |
| NZ533368A (en) * | 2004-06-08 | 2008-06-30 | Univ Waikato | Isolation process |
| CA2615607A1 (en) * | 2005-07-21 | 2007-02-08 | Fmc Biopolymer As | Medical devices coated with a fast dissolving biocompatible coating |
| US20070098671A1 (en) * | 2005-11-02 | 2007-05-03 | Martin Gregory D | Composition and method of treatment for irritated skin |
| GB0525504D0 (en) | 2005-12-14 | 2006-01-25 | Bristol Myers Squibb Co | Antimicrobial composition |
| FR2899479B1 (fr) * | 2006-04-10 | 2009-07-24 | Agelys Lab | Composition cicatrisante |
| CN101679935B (zh) | 2007-05-03 | 2013-10-09 | 托比亚斯·奥洛夫松 | 从新鲜蜂蜜或蜜蜂的产蜜道中分离的新细菌 |
| JP5192860B2 (ja) * | 2008-03-18 | 2013-05-08 | 日本特殊陶業株式会社 | パッケージ |
| GB0810404D0 (en) * | 2008-06-06 | 2008-07-09 | Manuka Medical Ltd | Compositions |
| JP5473387B2 (ja) * | 2009-04-24 | 2014-04-16 | ユニメディカル株式会社 | 創傷被覆剤及びその製造方法 |
| WO2011046454A1 (en) * | 2009-10-14 | 2011-04-21 | Laurence Greig Limited | Treatment of molluscum contagiosum using honey |
| GB201020236D0 (en) | 2010-11-30 | 2011-01-12 | Convatec Technologies Inc | A composition for detecting biofilms on viable tissues |
| CN102406958B (zh) * | 2011-12-02 | 2014-04-09 | 褚加冕 | 一种杀菌蜂蜜敷料的制备方法 |
| CN105008611A (zh) | 2012-12-20 | 2015-10-28 | 康沃特克科技公司 | 化学改性的纤维素纤维的处理 |
| GB201308770D0 (en) * | 2013-05-15 | 2013-06-26 | Convatec Technologies Inc | Wound Dressing Comprising an Antimicrobial Composition |
| JP2016531098A (ja) * | 2013-07-09 | 2016-10-06 | マヌカメッド リミテッド | 創傷被覆材 |
| US20150030688A1 (en) * | 2013-07-25 | 2015-01-29 | Saint Louis University | Honey and growth factor eluting scaffold for wound healing and tissue engineering |
| US10086017B2 (en) * | 2013-09-19 | 2018-10-02 | Medline Industries, Inc. | Wound dressing containing polysaccharides |
| US10342891B2 (en) | 2013-09-19 | 2019-07-09 | Medline Industries, Inc. | Wound dressing containing saccharide and collagen |
| JP6825913B2 (ja) | 2014-04-30 | 2021-02-03 | マトケ・ホールディングス・リミテッド | 抗菌組成物 |
| FR3020948B1 (fr) * | 2014-05-14 | 2018-04-06 | Melipharm | Composition antimicrobienne |
| US10287641B2 (en) | 2014-08-14 | 2019-05-14 | Concellae Ab | Lactobacillus apinorum and Lactobacillus mellifer from honeybees in medical, food and feed applications |
| WO2016123539A1 (en) | 2015-01-29 | 2016-08-04 | Wardell Mark R | Wound healing compositions involving medicinal honey, mineral ions, and methylglyoxal, and methods of use |
| US20180236009A1 (en) * | 2017-02-22 | 2018-08-23 | San Melix Laboratories, Inc. | Buckwheat honey and bacitracin wound-healing dressing |
| GB2550301B (en) * | 2015-02-03 | 2019-12-11 | Matoke Holdings Ltd | Antimicrobial fibers and compositions |
| US10471106B2 (en) | 2015-06-16 | 2019-11-12 | George D. Petito | Composition having hydrolyzed collagen and manuka honey |
| WO2018065789A1 (en) * | 2016-10-06 | 2018-04-12 | Matoke Holdings Limited | Antimicrobial compositions |
| GB201716986D0 (en) | 2017-10-16 | 2017-11-29 | Matoke Holdings Ltd | Antimicrobial compositions |
| WO2022055848A1 (en) * | 2020-09-08 | 2022-03-17 | Preco, Inc. | Low gsm fiber web and method of making same |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2000009176A1 (en) * | 1998-08-11 | 2000-02-24 | Susanna Elizabeth Chalmers | A wound treatment composition and a wound dressing containing it |
| AU781878B2 (en) * | 1999-12-09 | 2005-06-16 | Derma Sciences, Inc. | Use of honey in medical dressings |
| NZ505514A (en) * | 2000-06-30 | 2003-02-28 | Bee & Herbal New Zealand Ltd | Method of manufacturing a wound dressing for the application of honey |
| GB0110715D0 (en) * | 2001-05-02 | 2001-06-27 | Acordis Speciality Fibres Ltd | Wound dressing |
| GB2382527A (en) | 2001-12-03 | 2003-06-04 | Acordis Speciality Fibres Ltd | Wound dressings |
-
2001
- 2001-12-03 GB GB0128936A patent/GB2382527A/en not_active Withdrawn
-
2002
- 2002-12-02 ES ES02804300T patent/ES2333112T3/es not_active Expired - Lifetime
- 2002-12-02 WO PCT/GB2002/005441 patent/WO2003047642A1/en not_active Ceased
- 2002-12-02 JP JP2003548896A patent/JP2005511146A/ja active Pending
- 2002-12-02 NZ NZ545248A patent/NZ545248A/en not_active IP Right Cessation
- 2002-12-02 CA CA2469033A patent/CA2469033C/en not_active Expired - Lifetime
- 2002-12-02 US US10/497,445 patent/US20050033213A1/en not_active Abandoned
- 2002-12-02 DE DE60233343T patent/DE60233343D1/de not_active Expired - Lifetime
- 2002-12-02 AT AT02804300T patent/ATE439149T1/de not_active IP Right Cessation
- 2002-12-02 EP EP02804300A patent/EP1450871B1/en not_active Expired - Lifetime
- 2002-12-02 AU AU2002365662A patent/AU2002365662B2/en not_active Expired
-
2008
- 2008-04-23 US US12/108,421 patent/US8303551B2/en not_active Expired - Fee Related
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12419917B2 (en) | 2021-04-23 | 2025-09-23 | Ndal Mfg Inc | Compositions and methods for treatment of conditions using fractionated honey |
Also Published As
| Publication number | Publication date |
|---|---|
| EP1450871A1 (en) | 2004-09-01 |
| DE60233343D1 (de) | 2009-09-24 |
| ES2333112T3 (es) | 2010-02-17 |
| JP2005511146A (ja) | 2005-04-28 |
| WO2003047642A1 (en) | 2003-06-12 |
| CA2469033A1 (en) | 2003-06-12 |
| ATE439149T1 (de) | 2009-08-15 |
| GB2382527A (en) | 2003-06-04 |
| US8303551B2 (en) | 2012-11-06 |
| AU2002365662B2 (en) | 2008-06-19 |
| US20090012440A1 (en) | 2009-01-08 |
| CA2469033C (en) | 2010-09-14 |
| AU2002365662A1 (en) | 2003-06-17 |
| US20050033213A1 (en) | 2005-02-10 |
| EP1450871B1 (en) | 2009-08-12 |
| GB0128936D0 (en) | 2002-01-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US8303551B2 (en) | Wound dressings | |
| JP5691099B2 (ja) | 組成物 | |
| DE2403269C2 (enExample) | ||
| CA2352296C (en) | Collagen hemostatic fibers | |
| FI115608B (fi) | Haavakääre | |
| US7604816B2 (en) | Bio-absorbable collagen-based wound dressing | |
| US20060211972A1 (en) | Wound dressing | |
| KR20000016251A (ko) | 상처용 드레싱 | |
| JP4808402B2 (ja) | 陰イオン多糖と銀の複合体を含む創傷包帯材料 | |
| CA2155518A1 (en) | Pharmaceutical compositions comprising a spongy material consisting of ester derivatives of hyarulonic acid combined with other pharmacologically active substances | |
| HU201683B (en) | Process for producing pharmaceutical compositions for promoting healing of wounds | |
| US20130018334A1 (en) | Biodegradable wound care products with biocompatible artificial skin treatment and healing accelerator | |
| JPH0566149B2 (enExample) | ||
| RU2851874C1 (ru) | Медицинский гемостатический бинт | |
| Elsner et al. | Novel composite antibiotic-eluting structures for wound healing applications | |
| AU719419C (en) | Wound dressing | |
| RO135509A2 (ro) | Bioma- teriale textile cu efect antiinflamator şi procedeul de obţinere a acestora | |
| JPS6340543B2 (enExample) | ||
| MXPA98010047A (en) | Aposito for heri |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RENW | Renewal (renewal fees accepted) | ||
| PSEA | Patent sealed | ||
| RENW | Renewal (renewal fees accepted) | ||
| RENW | Renewal (renewal fees accepted) | ||
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 7 YEARS UNTIL 02 DEC 2022 BY CREATEIP Effective date: 20140912 |
|
| EXPY | Patent expired |